Apolipoprotein E Polymorphism and Brain Morphology in Mild Cognitive Impairment
暂无分享,去创建一个
Philipp A. Thomann | Johannes Schröder | Pablo Toro | M. Essig | P. Thomann | J. Schröder | Marco Essig | P. Toro | Vasco Dos Santos | Ann-Sophie Roth | Vasco Dos Santos | Ann-Sophie Roth
[1] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[2] A D Roses,et al. Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[4] R. Lévy,et al. Aging-Associated Cognitive Decline , 1994, International Psychogeriatrics.
[5] John J Sidtis,et al. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.
[6] Charles DeCarli,et al. Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .
[7] G. Schmitz,et al. High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. , 1999, Clinical chemistry.
[8] Pei-Ning Wang,et al. The MCI study in Taiwan. , 2006, Acta neurologica Taiwanica.
[9] H C Charles,et al. Impact of APOE in mild cognitive impairment , 2004, Neurology.
[10] J. Wesson Ashford,et al. ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.
[11] Daniel Bandy,et al. Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. , 2007, The American journal of psychiatry.
[12] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[13] Jim Mintz,et al. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. , 2006, Archives of general psychiatry.
[14] L Nyberg,et al. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? , 2006, Neurology.
[15] Charles DeCarli,et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. , 2005, Archives of neurology.
[16] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[17] Andrew J. Saykin,et al. Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.
[18] R J Havel,et al. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.
[19] Richard J. Caselli,et al. Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates , 2007 .
[20] Yadong Huang. Apolipoprotein E and Alzheimer disease , 2006, Neurology.
[21] Peter Schönknecht,et al. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. , 2005, The American journal of psychiatry.
[22] G J Tsongalis,et al. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. , 2006, Neurology.
[23] R Levy,et al. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. , 1994, International psychogeriatrics.
[24] Nicolas Cherbuin,et al. Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.
[25] H. Soininen,et al. Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study , 2008, Neurodegenerative Diseases.
[26] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[27] L Nyberg,et al. Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.
[28] Karen Ritchie,et al. Classification criteria for mild cognitive impairment: A population-based validation study , 2001 .
[29] Marina Boccardi,et al. The Effect of Apolipoprotein Polymorphism on Brain in Mild Cognitive Impairment: A Voxel-Based Morphometric Study , 2006, Dementia and Geriatric Cognitive Disorders.
[30] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[31] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.